Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Columbia University
National Institutes of Health Clinical Center (CC)
BeiGene
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Memorial Sloan Kettering Cancer Center